Playback speed
10 seconds
ASH 2022 Phase II DEDALO Trial: Daratumumab + Pomalidomide & Dexamethasone (DPd) in Patients With R/R MM and 17p Deletion
By
ASH 2022 Conference Coverage
FEATURING
Vittorio Montefusco
By
ASH 2022 Conference Coverage
FEATURING
Vittorio Montefusco
34 views
December 28, 2022
Login to view comments.
Click here to Login